Adagene Inc.
About Adagene Inc.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Public Offering T: - FT: Public Offering |
A: 70000000 MR: - FA: US$70.0 million FAN: 70000000 |
D: 2026-04-02 FD: 2026-04-02 |
5 investors |
| 2 |
RT: Equity Investment T: - FT: Equity Investment |
A: 25000000 MR: - FA: up to $25 million FAN: 25000000 |
D: 2025-07-01 FD: 2025-07-01 |
1 investors |
Growth Metrics
Team & Leadership
Peter Luo
Chairman, CEO & President of R&D
Qinghai Zhao
Chief Manufacturing Officer
Man Kin Tam
Chief Financial Officer
Mickael Chane-Du
Chief Strategy Officer
Jiping Zha
Executive Vice President, Clinical Development
Yan Li
Senior Vice President, Bioinformatics and Information Technology
Recent News
Adagene Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- adagene.com
- Industries
- Biotechnology
- Company Size
- ~560 employees (est.)
- Locations
-
SAN DIEGO and SUZHOU, China
San Diego and Suzhou, China
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro